Abeona Therapeutics(ABEO)
CLEVELAND, OHBiotechnology
Focus: Abeona Therapeutics is a public biotech company focused on gene transfer and cell therapies for rare genetic diseases, including Sanfilippo syndrome, epidermolysis bullosa, and mucopolysaccharidosis. With 1,001-5,000 employees and a Cleveland headquarters, the company operates at mid-cap biotech scale.
Profile data last refreshed 6h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Employees
1001-5000
Open Jobs
2+2 this month
Stable — net +2 jobs in 30d
2 added, 0 removed. Backfill posture.
Should You Work at Abeona Therapeutics?
AI assessmentAbeona is a high-risk, high-science-exposure play best suited for early-stage biotech scientists willing to tolerate financial instability for cutting-edge rare disease genetics work.
Why Work Here
- Exposure to cutting-edge gene transfer and cell therapy modalities addressing severe rare genetic diseases with high unmet need
- Balanced pipeline with 9 active trials including Phase 3 programs (EB-101, MSI-78) offering near-term visibility to clinical catalysts
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$6M
Pipeline & Clinical Trials
ABO-101
Mucopolysaccharidosis III-BClinical Trials (1)
NCT04655911A Long-term Follow-up Study of Patients With MPS IIIB Treated With ABO-101
N/AHelp build intelligence for Abeona Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.